Eraky A
Cureus. 2023; 15(2):e34593.
PMID: 36883085
PMC: 9985895.
DOI: 10.7759/cureus.34593.
Wang S, Pan C, Ma X, Yang C, Tang L, Huang J
Front Genet. 2022; 12:736441.
PMID: 35003205
PMC: 8727870.
DOI: 10.3389/fgene.2021.736441.
Sheng G, Gao Y, Yang Y, Wu H
Front Oncol. 2021; 11:780264.
PMID: 34956899
PMC: 8702962.
DOI: 10.3389/fonc.2021.780264.
Lin J, Maimaitiyiming A, Chen S, Xiao M, Xian Z
Aging (Albany NY). 2021; 13(7):10158-10174.
PMID: 33819184
PMC: 8064185.
DOI: 10.18632/aging.202778.
Yan Z, Yin H, Lin G
Onco Targets Ther. 2020; 13:10945-10957.
PMID: 33149610
PMC: 7604853.
DOI: 10.2147/OTT.S233000.
Non-Coding and Regulatory RNAs as Epigenetic Remodelers of Fatty Acid Homeostasis in Cancer.
Cruz-Gil S, Fernandez L, Sanchez-Martinez R, Gomez de Cedron M, Ramirez de Molina A
Cancers (Basel). 2020; 12(10).
PMID: 33050166
PMC: 7599548.
DOI: 10.3390/cancers12102890.
MicroRNA-195 controls MICU1 expression and tumor growth in ovarian cancer.
Rao G, Dwivedi S, Zhang Y, Dey A, Shameer K, Karthik R
EMBO Rep. 2020; 21(10):e48483.
PMID: 32851774
PMC: 7534609.
DOI: 10.15252/embr.201948483.
Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network.
Wang X, Ding Y, Wang J, Wu Y
Front Genet. 2020; 10:1398.
PMID: 32047516
PMC: 6997565.
DOI: 10.3389/fgene.2019.01398.
The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5.
Yu X, Zhang Y, Wu B, Kurie J, Pertsemlidis A
Mol Ther Oncolytics. 2019; 14:288-298.
PMID: 31508486
PMC: 6727248.
DOI: 10.1016/j.omto.2019.07.004.
MicroRNA-106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma.
Xu K, Xiong W, Zhao S, Wang B
Oncol Lett. 2019; 18(3):3342-3348.
PMID: 31452813
PMC: 6704313.
DOI: 10.3892/ol.2019.10666.
Role of microRNA-15a-5p in the atherosclerotic inflammatory response and arterial injury improvement of diabetic by targeting FASN.
Liu Y, Liu L, Jia Y, Sun Y, Ma F
Biosci Rep. 2019; 39(7).
PMID: 31182467
PMC: 6603278.
DOI: 10.1042/BSR20181852.
miRNA signatures in childhood sarcomas and their clinical implications.
Viera G, Salomao K, de Sousa G, Baroni M, Delsin L, Pezuk J
Clin Transl Oncol. 2019; 21(12):1583-1623.
PMID: 30949930
DOI: 10.1007/s12094-019-02104-z.
MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression.
Xue M, Li G, Sun P, Zhang D, Fang X, Li W
Am J Transl Res. 2019; 11(2):885-894.
PMID: 30899388
PMC: 6413272.
The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
Shekhar R, Priyanka P, Kumar P, Ghosh T, Khan M, Nagarajan P
J Biol Chem. 2019; 294(12):4381-4400.
PMID: 30679313
PMC: 6433048.
DOI: 10.1074/jbc.RA118.005778.
microRNA-Mediated Tumor-Microbiota Metabolic Interactions in Colorectal Cancer.
Yuan C, Subramanian S
DNA Cell Biol. 2019; 38(4):281-285.
PMID: 30668143
PMC: 6477581.
DOI: 10.1089/dna.2018.4579.
Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.
Yu J, Pi W, Cao Y, Peng A, Cao Z, Liu J
Cancer Manag Res. 2018; 10:6305-6315.
PMID: 30568492
PMC: 6267740.
DOI: 10.2147/CMAR.S185090.
Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases.
Tsunoda Y, Sasaki A, Sakamoto N, Teraoka K, Nakagawa R, Koshida Y
Breast Cancer (Dove Med Press). 2018; 10:195-199.
PMID: 30538543
PMC: 6257358.
DOI: 10.2147/BCTT.S181652.
MicroRNA-195: a review of its role in cancers.
Yu W, Liang X, Li X, Zhang Y, Sun Z, Liu Y
Onco Targets Ther. 2018; 11:7109-7123.
PMID: 30410367
PMC: 6200091.
DOI: 10.2147/OTT.S183600.
miRNA-1284, a regulator of HMGB1, inhibits cell proliferation and migration in osteosarcoma.
Lv S, Guan M
Biosci Rep. 2018; 38(4).
PMID: 29899164
PMC: 6043716.
DOI: 10.1042/BSR20171675.
miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
Yu X, Zhang Y, Cavazos D, Ma X, Zhao Z, Du L
Cell Death Dis. 2018; 9(2):193.
PMID: 29416000
PMC: 5833354.
DOI: 10.1038/s41419-017-0219-9.